Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.

Scientific reports - 4 Sept 2015

Park Junseong, Lee Jungsul, Choi Chulhee

Abstract excerpt

In the post-genomic era, many researchers have taken a systematic approach to identifying abnormal genes associated with various diseases. However, the gold standard has not been established, and most of these abnormalities are difficult to be rehabilitated in real clinical settings. In addition to identifying abnormal genes, for a practical purpose, it is necessary to investigate abnormality diversity. In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Computer Simulation
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to Gene Expression Profiling

Share to Molecular Targeted Therapy

Share to Neoplasm Proteins

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26336805
DOI: 10.1038/srep13576
PMCID: PMC4559746

Genes

PTPRF
RICTOR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of drug-targetable genes by defining modes of abnormality in gene expression.PMID 26336805Read ↗

Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway AnalysisSemantic proximity Read ↗

Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signaturesSemantic proximity Read ↗

Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity mapSemantic proximity Read ↗

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of CancerSemantic proximity Read ↗

Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targetsSemantic proximity Read ↗

Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues.Semantic proximity Read ↗

A systematic assessment of linking gene expression with genetic variants for prioritizing candidate targets.Semantic proximity Read ↗

Integrating ensemble systems biology feature selection and bimodal deep neural network for breast cancer prognosis predictionSemantic proximity Read ↗

Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity mapSemantic proximity Read ↗

Identification of informative genes and sub-pathways using Improved Differential Expression Analysis for Pathways (iDEAP) for cancer classificationSemantic proximity Read ↗

GIP: A Gene network-based integrative approach for Inferring disease-associated signaling PathwaysSemantic proximity Read ↗

Predicting mechanism of action of cellular perturbations with pathway activity signaturesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.